MSB 3.21% $1.13 mesoblast limited

banter and General Discussion, page-4772

  1. 17,010 Posts.
    lightbulb Created with Sketch. 2412
    Actually IMO the fact that the re-submission has taken such a long time does indeed point to a problem in resolving the issues that the FDA have raised. Instead of acknowledging that, some posters prefer to suggest that the FDA is somehow slowing down the re-submission or that the company has already done it but just hasn't announced it.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.